96 related articles for article (PubMed ID: 34211136)
1. A proposed protocol of intravitreal injection of methotrexate for treatment of primary vitreoretinal lymphoma.
Zhou N; Xu X; Liu Y; Wang Y; Wei W
Eye (Lond); 2022 Jul; 36(7):1448-1455. PubMed ID: 34211136
[TBL] [Abstract][Full Text] [Related]
2. Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma.
Motomura Y; Yoshifuji K; Tachibana T; Takase H; Arai A; Tanaka K; Okada K; Nogami A; Umezawa Y; Sakashita C; Yamamoto M; Mori T; Nagao T
Br J Haematol; 2024 Apr; 204(4):1279-1287. PubMed ID: 38131400
[TBL] [Abstract][Full Text] [Related]
3. INTRAVITREAL MELPHALAN INJECTION AS A SECOND-LINE LOCAL THERAPY IN VITREORETINAL LYMPHOMA: Case Series.
Guneri Beser B; Demirci H
Retina; 2024 Feb; 44(2):353-359. PubMed ID: 37883576
[TBL] [Abstract][Full Text] [Related]
4. Prognosis, Risk Factors, and Clinical Features of Intraocular Recurrence in Primary Vitreoretinal Lymphoma.
Liu S; Jiang T; Gu J; Zhou X; Chen W; Ping B; Zhou Y; Zhang T; Huang X; Xu G; Chang Q
Ophthalmol Retina; 2024 Apr; 8(4):317-324. PubMed ID: 37918656
[TBL] [Abstract][Full Text] [Related]
5. Comparative Molecular Analysis of Primary Central Nervous System Lymphomas and Matched Vitreoretinal Lymphomas by Vitreous Liquid Biopsy.
Balikov DA; Hu K; Liu CJ; Betz BL; Chinnaiyan AM; Devisetty LV; Venneti S; Tomlins SA; Cani AK; Rao RC
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576156
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate plus idarubicin improves outcome of patients with primary central nervous system lymphoma.
Fan N; Zhang L; Xu X; Chen B; Zhu C; Li P; Chen Z; Ding T; Ma Y; Yuan Y; Lin Z
Oncotarget; 2017 Aug; 8(32):53701-53713. PubMed ID: 28881844
[TBL] [Abstract][Full Text] [Related]
7. Intraocular methotrexate for epithelial downgrowth: long-term outcomes in a multicentre case series.
Hébert M; Kyrillos R; Snyder ME; Mackool RJ; Francis JH; Wu HK; Riemann CD; Légaré ME
Br J Ophthalmol; 2023 Sep; 107(9):1383-1389. PubMed ID: 35649694
[TBL] [Abstract][Full Text] [Related]
8. An audit of retinal lymphoma treatment at the University of California San Francisco.
Damato B; Bever GJ; Kim DJ; Afshar AR; Rubenstein JL
Eye (Lond); 2020 Mar; 34(3):515-522. PubMed ID: 31358925
[TBL] [Abstract][Full Text] [Related]
9. Primary Vitreoretinal Lymphoma -- A Review.
Araujo I; Coupland SE
Asia Pac J Ophthalmol (Phila); 2017; 6(3):283-289. PubMed ID: 28558176
[TBL] [Abstract][Full Text] [Related]
10. Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas.
Elbert M; Neumann F; Kiefer M; Christofyllakis K; Balensiefer B; Kos I; Carbon G; Kaddu-Mulindwa D; Bittenbring JT; Fadle N; Regitz E; Fend F; Bonzheim I; Thurner L; Bewarder M
Sci Rep; 2024 Apr; 14(1):9571. PubMed ID: 38671086
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of etoposide and cytarabine as consolidation in elderly patients with primary CNS lymphoma.
Kim YR; Cho H; Kim SJ; Chung H; Kook HW; Jang JE; Cheong JW; Kim JS
Oncologist; 2024 Apr; ():. PubMed ID: 38581718
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal Methotrexate.
Abdi F; Mohammadi SS; Falavarjani KG
J Ophthalmic Vis Res; 2021; 16(4):657-669. PubMed ID: 34840688
[TBL] [Abstract][Full Text] [Related]
13. Multimodal imaging in a case of presumed secondary vitreoretinal lymphoma presenting with inner retina and optic nerve head infiltration.
Levine ES; Batra NN
Am J Ophthalmol Case Rep; 2024 Jun; 34():102040. PubMed ID: 38532849
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Histopathologic Findings and Safety of Intravitreal Ketamine Administration on Vitreoretinal Tissue in Rat Model: A Pilot Study.
Sanatkar M; Nozarian Z; Abdi P; Bazvand F
J Curr Ophthalmol; 2023; 35(3):297-300. PubMed ID: 38681690
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal Injections: Improving Sustainability by Reducing Clinical Waste.
Birtel J; Hammer M; Feltgen N; Pauleikhoff L; Ong AY; Geerling G; Spitzer MS; Charbel Issa P
Klin Monbl Augenheilkd; 2024 Apr; ():. PubMed ID: 38574679
[TBL] [Abstract][Full Text] [Related]
16. Primary vitreoretinal lymphoma: short review of the literature, results of a European survey and French guidelines of the LOC network for diagnosis, treatment and follow-up.
Malaise D; Houillier C; Touitou V; Choquet S; Maloum K; Le Garff-Tavernier M; Davi F; Vincent-Salomon A; Feuvret L; Hoang-Xuan K; Cassoux N; Soussain C;
Curr Opin Oncol; 2021 Sep; 33(5):420-431. PubMed ID: 34292201
[TBL] [Abstract][Full Text] [Related]
17. Vitreoretinal Lymphoma.
Sobolewska B; Chee SP; Zaguia F; Goldstein DA; Smith JR; Fend F; Mochizuki M; Zierhut M
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439078
[TBL] [Abstract][Full Text] [Related]
18. Lenalidomide and Rituximab Regimen Combined With Intravitreal Methotrexate Followed by Lenalidomide Maintenance for Primary Vitreoretinal Lymphoma: A Prospective Phase II Study.
Zhang Y; Zhang X; Zou D; Yin J; Zhang L; Wang X; Jia C; Wang W; Zhao D; Zhou D; Zhang W; Zhang M
Front Oncol; 2021; 11():701507. PubMed ID: 34249763
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives.
Kaburaki T; Taoka K
Jpn J Ophthalmol; 2023 Jul; 67(4):363-381. PubMed ID: 37209195
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
